Subthalamic stimulation improves levodopa responsive symptoms in a case of progressive supranuclear palsy

Parkinsonism and Related Disorders

Volumn 14, Issue 4, 2008, Pages 348-352

  Bergmann, Kenneth J ^a   Salak, Vicky L ^a  

^a Movement Disorders Program   (United States)

Author keywords

DBS; Deep brain stimulation; Progressive supranuclear palsy; PSP; STN; Subthalamic nucleus

Indexed keywords

AMANTADINE; CARBIDOPA PLUS LEVODOPA; ENTACAPONE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; DYSKINESIA; DYSTONIA; FEMALE; FOOT EDEMA; GLOBUS PALLIDUS; HUMAN; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SOMNOLENCE; SUBTHALAMIC NUCLEUS;

DEEP BRAIN STIMULATION; DOPAMINE AGENTS; FEMALE; HUMANS; LEVODOPA; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; SUBTHALAMIC NUCLEUS; SUPRANUCLEAR PALSY, PROGRESSIVE; TIME FACTORS;

EID: 44249102975     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.07.004     Document Type: Article

References (16)

1. Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, et al. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006 April 2.
2. Gilman S., May S.J., Shults C.W., Tanner C.M., Kukull W., Lee V.M., et al. The North American Multiple System Atrophy Study Group. J Neural Transm 112 12 (2005) 1687-1694
3. Williams D.R., de Silva R., Paviour D.C., Pittman A., Watt H.C., Kilford L., et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128 Pt 6 (2005) 1247-1258
4. Hughes A.J., Daniel S.E., and Lees A.J. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57 8 (2001) 1497-1499
5. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47 1 (1996) 1-9
6. Nieforth K.A., and Golbe L.I. Retrospective study of drug response in 87 patients with progressive supranuclear palsy. Clin Neuropharmacol 16 4 (1993) 338-346
7. Chou K.L., Forman M.S., Trojanowski J.Q., Hurtig H.I., and Baltuch G.H. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report. J Neurosurg 100 3 (2004) 553-556
8. Lezcano E., Gomez-Esteban J.C., Zarranz J.J., Alcaraz R., Atares B., Bilbao G., et al. Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report. Mov Disord 19 8 (2004) 973-977
9. Talmant V., Esposito P., Stilhart B., Mohr M., and Tranchant C. Subthalamic stimulation in a patient with multiple system atrophy: a clinicopathological report. Rev Neurol (Paris) 162 3 (2006) 363-370
10. Tarsy D., Apetauerova D., Ryan P., and Norregaard T. Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy. Neurology 61 2 (2003) 247-249
11. Visser-Vandewalle V., Temel Y., van der Linden C., Ackermans L., and Beuls E. Deep brain stimulation in movement disorders. The applications reconsidered. Acta Neurol (Belg) 104 1 (2004) 33-36
12. Morris H.R., Gibb G., Katzenschlager R., Wood N.W., Hanger D.P., Strand C., et al. Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain 125 Pt 5 (2002) 969-975
13. Steele J.C., Richardson J.C., and Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10 (1964) 333-359
14. Cubo E., Stebbins G.T., Golbe L.I., Nieves A., Leurgans S., Goetz C.G., et al. Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale. Mov Disord 15 2 (2000) 276-279
15. Kroonenberg P.M., Oort F.J., Stebbins G.T., Leurgans S.E., Cubo E., and Goetz C.G. Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations. BMC Med Res Methodol 6 (2006) 26
16. Guyatt G., Sackett D., Taylor D.W., Chong J., Roberts R., and Pugsley S. Determining optimal therapy-randomized trials in individual patients. N Engl J Med 314 14 (1986) 889-892